Having come closer to the end of the COVID-19 business crisis and now looking at the consequences for the third-party services market next year, I am increasingly optimistic that we will see an extremely strong year going forward. In fact, I believe it will be historically robust. Yet, COVID is still here, and the services market experienced a deceleration in growth this year. Here is a look at what is changing that picture for service provider firms as well as the implications for services customers.
The Future of Decentralized Clinical Trials Starts with a Patient-first Design Approach
The biggest benefit of Decentralized Clinical Trials (DCT) is the opportunity to [...]
